We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Ask ADVFN Intelligence (AI)
By Neil Haggerty Actavis PLC said Monday it has changed its name to Allergan PLC, three months after acquiring the maker of the antiwrinkle treatment Botox. The company will change its stock...
MADISON HEIGHTS, Mich., Dec. 4 /PRNewswire/ -- The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE:AGN) as its February 2010...
(Updates throughout with details on results, recent Botox filings, CEO and analyst comments, updated share price.) By Jon Kamp Of DOW JONES NEWSWIRES Allergan Inc.'s (AGN) third-quarter profit...
("Allergan 3Q Net Up 8% Amid Cost Cuts; 2009 View Raised," published at 9:41 a.m. EDT, incorrectly noted earnings including noncontrolling interest in describing total profit for the latest...
By Val Brickates Kennedy U.S. drug stocks edged higher in early trading Thursday, with shares of biotech groups BioMarin Pharmaceutical Inc. and Human Genome Sciences leading the pack. The NYSE...
Allergan Inc.'s (AGN) third-quarter profit rose 8% on higher sales and margins at the eye- and skin-care products company. The maker of Botox and the nation's largest seller of medical products...
Allergan Inc. (AGN) officials said Friday the drug maker's lawsuit against the government, seeking the right to discuss unapproved uses of its drug Botox with doctors, is a company-specific issue...
Allergan Inc. (AGN) officials said Friday that a lawsuit filed against the government regarding the company's ability to discuss unapproved uses of its drug Botox with doctors is a...
CHICAGO, Sept. 29 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for AAPL, AA, KMX, AGN, and ANN. Seven Summits Strategic Investments' PriceWatch Alerts are available at...
The Web site of Allergan Inc.'s (AGN) Latisse is misleading because it suggests the company's eyelash thickener is more safe than proven, federal regulators said on Wednesday. In a letter to...
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.02 | 2.94117647059 | 0.68 | 0.72 | 0.63 | 44521 | 0.634599 | DE |
| 4 | 0.07 | 11.1111111111 | 0.63 | 0.72 | 0.605 | 73798 | 0.640573 | DE |
| 12 | -0.055 | -7.28476821192 | 0.755 | 0.8 | 0.595 | 114912 | 0.67633888 | DE |
| 26 | -0.13 | -15.6626506024 | 0.83 | 0.94 | 0.595 | 131120 | 0.73343577 | DE |
| 52 | 0.09 | 14.7540983607 | 0.61 | 0.985 | 0.515 | 170764 | 0.71983488 | DE |
| 156 | -0.035 | -4.7619047619 | 0.735 | 0.985 | 0.295 | 111913 | 0.60369086 | DE |
| 260 | 0.43 | 159.259259259 | 0.27 | 1.02 | 0.18 | 161423 | 0.49776458 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
